China Cord Blood Corporation. (CO) 4.75 $CO
Keep An Eye On China Cord Blood
Jack Banser - at Seeking Alpha - Tue Feb 10, 8:19AM CST
CO: 4.75 (-0.06)
China Cord Blood Corporation and Cord Blood Registry Enter into Strategic Collaboration
PR Newswire - Wed Jan 28, 7:00AM CST
China Cord Blood Corporation (CCBC, NYSE: CO), China's first and largest umbilical cord blood bank, and Cord Blood Registry® (CBR®), the world's largest newborn stem cell company, today entered into a memorandum of understanding regarding their strategic collaboration in China and the United States. The two prominent cord blood banks will share data on cord blood collection, processing and storage to advance international standards. The companies will also work together under the memorandum, to develop a family disease registry for CCBC's clients in China and jointly support newborn stem cell-related clinical trials in the U.S. and China.
CO: 4.75 (-0.06)
Cord Blood Registry and China Cord Blood Corporation Enter into Strategic Collaboration
PR Newswire - Wed Jan 28, 7:00AM CST
Cord Blood Registry® (CBR®), the world's largest newborn stem cell company, and China Cord Blood Corporation (CCBC [NYSE: CO]), China's first and largest umbilical cord blood bank, today entered into a memorandum of understanding regarding their strategic collaboration in China and the United States. The two prominent cord blood banks will share data on cord blood collection, processing and storage to advance international standards. The companies will also work together under the memorandum, to develop a family disease registry for CCBC's clients in China and jointly support newborn stem cell-related clinical trials in the U.S. and China.
CO: 4.75 (-0.06)
InsiderInsights.com Daily Round Up 1/21/15: ATLS, BH, OPK, LINE
InsiderInsights - at Seeking Alpha - Thu Jan 22, 7:01AM CST
EXLS: 31.34 (-0.05), ATLS: 30.17 (+0.27), DAL: 44.50 (-0.31), UPLD: 7.22 (-0.02), QTWO: 20.73 (+1.65), BURL: 51.91 (-0.56), INTC: 34.36 (+0.23), GOOG: 549.01 (+6.08), K: 63.20 (-0.10), PBCT: 14.95 (unch), BH: 416.41 (-1.55), CMC: 15.40 (+0.37), OPK: 13.80 (-0.28), CAS: 6.14 (-0.01), UBA: 22.84 (-0.21), CO: 4.75 (-0.06), LINE: 12.94 (+0.40), BRX: 26.27 (-0.07), VGR: 22.52 (-0.26), CRM: 62.85 (+1.59)
InsiderInsights.com Daily Round Up 1/14/15: OPK, REN, VEEV, CO
InsiderInsights - at Seeking Alpha - Thu Jan 15, 10:41AM CST
AFAM: 30.88 (+0.37), BBW: 20.94 (+0.14), BBY: 39.11 (-0.08), GOOG: 549.01 (+6.08), VEEV: 30.12 (+0.17), BBBY: 77.91 (-0.49), OPK: 13.80 (-0.28), REN: 1.14 (unch), AVHI: 15.16 (+0.04), GOOGL: 551.16 (+5.15), SIX: 45.11 (-0.05), BNCL: 11.54 (-0.02), CO: 4.75 (-0.06), GRPN: 7.97 (+0.51), SPN: 21.72 (+0.89), ALCO: 45.40 (+1.44), KPTI: 27.12 (-0.13), CRM: 62.85 (+1.59)
InsiderInsights.com Daily Round Up 12/18/14: Agios Pharmaceuticals, Inc.,Unit Corporation, China Cord Blood Corporation, Saba Software, Inc.
InsiderInsights - at Seeking Alpha - Fri Dec 19, 9:49AM CST
FLXN: 21.29 (+0.28), NLSN: 45.59 (+2.02), HDP: 22.81 (+0.83), HDS: 28.62 (+0.24), PAH: 22.68 (+0.14), BURL: 51.91 (-0.56), SNI: 73.00 (+0.39), MFRM: 62.22 (-0.12), MPG: 18.90 (+0.73), UNT: 33.26 (+1.10), BFAM: 50.19 (+1.15), DYN: 28.39 (+0.01), AGIO: 118.55 (+0.11), WES: 71.50 (+0.18), CO: 4.75 (-0.06), KTEC: 12.53 (-0.02)
China Cord Blood Corporation Announces Results of 2014 Annual General Meeting
PR Newswire - Thu Dec 11, 7:30AM CST
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"
, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2014 Annual General Meeting, which was held on December 11, 2014, in Hong Kong, China.
CO: 4.75 (-0.06)
InsiderInsights.com Daily Round Up 12/10/14: PSEC, TWI, SGEN, ATLS
InsiderInsights - at Seeking Alpha - Thu Dec 11, 12:18AM CST
TRVN: 5.42 (+0.15), HSGX: 8.61 (-0.07), VR: 42.10 (+0.07), LBTYK: 50.78 (+2.40), ATLS: 30.17 (+0.27), UHS: 104.93 (+0.84), CLH: 49.57 (-0.66), WMS: 25.03 (+0.36), ALEX: 40.08 (+0.12), CDW: 37.03 (+0.63), BABY: 36.96 (-0.03), PRSS: 2.95 (-0.08), SGEN: 31.57 (+0.36), CO: 4.75 (-0.06), HBI: 119.12 (+1.27), TWI: 9.63 (+0.04), HSIC: 143.18 (+0.72), PSEC: 8.67 (+0.07), XLRN: 38.02 (+0.07)
InsiderInsights.com Daily Round Up 12/5/14: HEES, CCC, CUDA, SC
InsiderInsights - at Seeking Alpha - Sun Dec 07, 2:27AM CST
SC: 22.11 (+0.38), PIH: 7.64 (-0.01), AAP: 150.16 (-1.26), PCI: 20.56 (+0.02), DLR: 68.65 (-2.07), PPR: 5.37 (+0.03), LLY: 70.56 (+0.03), SUNS: 15.79 (-0.05), BMY: 60.04 (+0.56), CCC: 20.15 (+0.28), GV: 2.45 (+0.02), RCL: 75.56 (-1.19), ACE: 113.05 (+0.09), FOX: 33.66 (+0.35), ROC: 79.20 (+0.33), CUDA: 35.68 (-1.14), HEES: 22.94 (+0.77), CO: 4.75 (-0.06), EPE: 12.90 (+0.56)
China Cord Blood's (CO) CEO Tina Zheng on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 27, 2:10AM CST
CO: 4.75 (-0.06)
China Cord Blood ups earnings 9% in FQ2
Seeking Alpha - at Seeking Alpha - Wed Nov 26, 6:24AM CST
CO: 4.75 (-0.06)
China Cord Blood posts 2Q profit
Automated Insights - Tue Nov 25, 3:39PM CST
CENTRAL HONG KONG, Hong Kong (AP) _ China Cord Blood Corp. (CO) on Tuesday reported earnings of $4.4 million, or 6 cents per share, in its fiscal second quarter.
CO: 4.75 (-0.06)
China Cord Blood EPS in-line, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 3:19PM CST
CO: 4.75 (-0.06)
China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2015
PR Newswire - Tue Nov 25, 3:05PM CST
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company" , China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial results for the second quarter and first half of fiscal year 2015 ended September 30, 2014.
CO: 4.75 (-0.06)
China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2015 Financial Results
PR Newswire - Tue Nov 18, 6:00AM CST
China Cord Blood Corporation (NYSE: CO) (the "Company" today announced its plan to release financial results for the second quarter and first half of fiscal year 2015 on Tuesday, November 25, 2014, after market close in the US.
CO: 4.75 (-0.06)
Complete 2015-16 Global Cord Blood Banking Industry Report
M2 - Fri Nov 14, 6:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/cr26gf/complete_201516) has announced the addition of the "Complete 2015-16 Global Cord Blood Banking Industry Report" report to their offering. The report is designed to guide the decision-making of cord blood banks worldwide, as well as to advise private, corporate, and institutional investors entering into this market. As such, it considers a range of metrics that impact the global cord blood banking market. It includes trend rate data for cord blood clinical trials, patents, grants, scientific publications and more. For instance, there are now more than 500 studies involving cord blood listed on www.ClinicalTrials.gov, and there have been hundreds of patents related to cord blood collection, processing, and storage filed through the United States Patent and Trademark Office (www.USPTO.gov). Globally, this patent count is even larger. Additionally, the year-over-year increase in scientific publications on PubMed.gov containing the term cord blood increased by 7.8% from 2013 to 2014. PubMed.gov is a global database of scientific publications containing more than 24 million citations for biomedical literature, which makes it an excellent resource for gauging biomedical research trends. However, grant rate data reveals that funding for cord blood related research has been declining from 2012 to present. This comprehensive overview consists of 4 documents: - Complete 2015-16 Global Cord Blood Industry Report - Cord Blood Survey: 600 Recent and Expectant Parents - Cord Blood Industry Database - Part 1 - Cord Blood Industry Database - Part 2 Key report findings include: - Market size determinations for the global cord blood market - Trend rate data for umbilical cord blood grants, patents, and scientific publications - Clinical trial rate analysis, including comparison of cord blood vs. cord tissue frequency - Rates of global cord blood storage (units per year) - Rates of global cord blood transplant (units per year) - Current and future conditions treatable with cord blood - Probability of requiring a stem cell transplant by age - Trends in medical opinions of cord blood banking - Changes in legislative support for cord blood banking - Critical events and emerging technologies within the cord blood industry - Competitive environment analysis, including assessment of cord blood market leaders - Influential alliances within the cord blood industry - "SWOT" analysis for global cord blood industry (Strengths, Weaknesses, Opportunities, Threats) - Crucial trends and unmet market needs Companies Mentioned - China Cord Blood Corporation - HealthBanks Biotech Company Ltd. - Cord Blood Registry For more information visit http://www.researchandmarkets.com/research/cr...ete_201516
CO: 4.75 (-0.06)
InsiderInsights.com Daily Round Up 11/10/14: CHK, TWX, SGEN, PBFX
InsiderInsights - at Seeking Alpha - Tue Nov 11, 2:29AM CST
HAS: 62.74 (+0.58), VR: 42.10 (+0.07), SEIC: 43.20 (+0.07), DRNA: 21.30 (-0.06), HA: 18.72 (-0.31), SAM: 303.26 (-0.97), PBFX: 23.40 (+0.95), AMRI: 16.94 (-0.28), GSAT: 2.40 (+0.08), TNET: 36.49 (+0.76), TWX: 83.87 (+0.56), HLT: 28.57 (+0.13), Q: 63.31 (+0.06), SGEN: 31.57 (+0.36), CF: 301.40 (-1.20), OPK: 13.80 (-0.28), CHK: 21.08 (+0.58), CNDO: 2.28 (+0.03), CO: 4.75 (-0.06), CPLA: 65.23 (-1.37)
China Cord Blood Corp: A Great Company With Substantial Potential Upside
The Kumquat - at Seeking Alpha - Tue Oct 28, 7:52AM CDT
CO: 4.75 (-0.06)
China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 11, 2014
PR Newswire - Fri Sep 26, 6:00AM CDT
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company" , China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 2014 annual general meeting of shareholders at its Hong Kong office at 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong, at 9:00 p.m. Hong Kong Time on December 11, 2014 (8:00 a.m. U.S. Eastern Time on December 11, 2014).
CO: 4.75 (-0.06)
CO, TSYS Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Wed Sep 24, 3:40AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of China Cord Blood Corp (NYSE:CO), TeleCommunication Systems Inc (NASDAQ:TSYS) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
TSYS: 3.28 (-0.03), CO: 4.75 (-0.06)
Keep An Eye On China Cord Blood
Jack Banser - at Seeking Alpha - Tue Feb 10, 8:19AM CST
CO: 4.75 (-0.06)
China Cord Blood Corporation and Cord Blood Registry Enter into Strategic Collaboration
PR Newswire - Wed Jan 28, 7:00AM CST
China Cord Blood Corporation (CCBC, NYSE: CO), China's first and largest umbilical cord blood bank, and Cord Blood Registry® (CBR®), the world's largest newborn stem cell company, today entered into a memorandum of understanding regarding their strategic collaboration in China and the United States. The two prominent cord blood banks will share data on cord blood collection, processing and storage to advance international standards. The companies will also work together under the memorandum, to develop a family disease registry for CCBC's clients in China and jointly support newborn stem cell-related clinical trials in the U.S. and China.
CO: 4.75 (-0.06)
Cord Blood Registry and China Cord Blood Corporation Enter into Strategic Collaboration
PR Newswire - Wed Jan 28, 7:00AM CST
Cord Blood Registry® (CBR®), the world's largest newborn stem cell company, and China Cord Blood Corporation (CCBC [NYSE: CO]), China's first and largest umbilical cord blood bank, today entered into a memorandum of understanding regarding their strategic collaboration in China and the United States. The two prominent cord blood banks will share data on cord blood collection, processing and storage to advance international standards. The companies will also work together under the memorandum, to develop a family disease registry for CCBC's clients in China and jointly support newborn stem cell-related clinical trials in the U.S. and China.
CO: 4.75 (-0.06)
InsiderInsights.com Daily Round Up 1/21/15: ATLS, BH, OPK, LINE
InsiderInsights - at Seeking Alpha - Thu Jan 22, 7:01AM CST
EXLS: 31.34 (-0.05), ATLS: 30.17 (+0.27), DAL: 44.50 (-0.31), UPLD: 7.22 (-0.02), QTWO: 20.73 (+1.65), BURL: 51.91 (-0.56), INTC: 34.36 (+0.23), GOOG: 549.01 (+6.08), K: 63.20 (-0.10), PBCT: 14.95 (unch), BH: 416.41 (-1.55), CMC: 15.40 (+0.37), OPK: 13.80 (-0.28), CAS: 6.14 (-0.01), UBA: 22.84 (-0.21), CO: 4.75 (-0.06), LINE: 12.94 (+0.40), BRX: 26.27 (-0.07), VGR: 22.52 (-0.26), CRM: 62.85 (+1.59)
InsiderInsights.com Daily Round Up 1/14/15: OPK, REN, VEEV, CO
InsiderInsights - at Seeking Alpha - Thu Jan 15, 10:41AM CST
AFAM: 30.88 (+0.37), BBW: 20.94 (+0.14), BBY: 39.11 (-0.08), GOOG: 549.01 (+6.08), VEEV: 30.12 (+0.17), BBBY: 77.91 (-0.49), OPK: 13.80 (-0.28), REN: 1.14 (unch), AVHI: 15.16 (+0.04), GOOGL: 551.16 (+5.15), SIX: 45.11 (-0.05), BNCL: 11.54 (-0.02), CO: 4.75 (-0.06), GRPN: 7.97 (+0.51), SPN: 21.72 (+0.89), ALCO: 45.40 (+1.44), KPTI: 27.12 (-0.13), CRM: 62.85 (+1.59)
InsiderInsights.com Daily Round Up 12/18/14: Agios Pharmaceuticals, Inc.,Unit Corporation, China Cord Blood Corporation, Saba Software, Inc.
InsiderInsights - at Seeking Alpha - Fri Dec 19, 9:49AM CST
FLXN: 21.29 (+0.28), NLSN: 45.59 (+2.02), HDP: 22.81 (+0.83), HDS: 28.62 (+0.24), PAH: 22.68 (+0.14), BURL: 51.91 (-0.56), SNI: 73.00 (+0.39), MFRM: 62.22 (-0.12), MPG: 18.90 (+0.73), UNT: 33.26 (+1.10), BFAM: 50.19 (+1.15), DYN: 28.39 (+0.01), AGIO: 118.55 (+0.11), WES: 71.50 (+0.18), CO: 4.75 (-0.06), KTEC: 12.53 (-0.02)
China Cord Blood Corporation Announces Results of 2014 Annual General Meeting
PR Newswire - Thu Dec 11, 7:30AM CST
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"
, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2014 Annual General Meeting, which was held on December 11, 2014, in Hong Kong, China. CO: 4.75 (-0.06)
InsiderInsights.com Daily Round Up 12/10/14: PSEC, TWI, SGEN, ATLS
InsiderInsights - at Seeking Alpha - Thu Dec 11, 12:18AM CST
TRVN: 5.42 (+0.15), HSGX: 8.61 (-0.07), VR: 42.10 (+0.07), LBTYK: 50.78 (+2.40), ATLS: 30.17 (+0.27), UHS: 104.93 (+0.84), CLH: 49.57 (-0.66), WMS: 25.03 (+0.36), ALEX: 40.08 (+0.12), CDW: 37.03 (+0.63), BABY: 36.96 (-0.03), PRSS: 2.95 (-0.08), SGEN: 31.57 (+0.36), CO: 4.75 (-0.06), HBI: 119.12 (+1.27), TWI: 9.63 (+0.04), HSIC: 143.18 (+0.72), PSEC: 8.67 (+0.07), XLRN: 38.02 (+0.07)
InsiderInsights.com Daily Round Up 12/5/14: HEES, CCC, CUDA, SC
InsiderInsights - at Seeking Alpha - Sun Dec 07, 2:27AM CST
SC: 22.11 (+0.38), PIH: 7.64 (-0.01), AAP: 150.16 (-1.26), PCI: 20.56 (+0.02), DLR: 68.65 (-2.07), PPR: 5.37 (+0.03), LLY: 70.56 (+0.03), SUNS: 15.79 (-0.05), BMY: 60.04 (+0.56), CCC: 20.15 (+0.28), GV: 2.45 (+0.02), RCL: 75.56 (-1.19), ACE: 113.05 (+0.09), FOX: 33.66 (+0.35), ROC: 79.20 (+0.33), CUDA: 35.68 (-1.14), HEES: 22.94 (+0.77), CO: 4.75 (-0.06), EPE: 12.90 (+0.56)
China Cord Blood's (CO) CEO Tina Zheng on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 27, 2:10AM CST
CO: 4.75 (-0.06)
China Cord Blood ups earnings 9% in FQ2
Seeking Alpha - at Seeking Alpha - Wed Nov 26, 6:24AM CST
CO: 4.75 (-0.06)
China Cord Blood posts 2Q profit
Automated Insights - Tue Nov 25, 3:39PM CST
CENTRAL HONG KONG, Hong Kong (AP) _ China Cord Blood Corp. (CO) on Tuesday reported earnings of $4.4 million, or 6 cents per share, in its fiscal second quarter.
CO: 4.75 (-0.06)
China Cord Blood EPS in-line, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 3:19PM CST
CO: 4.75 (-0.06)
China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2015
PR Newswire - Tue Nov 25, 3:05PM CST
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"
, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial results for the second quarter and first half of fiscal year 2015 ended September 30, 2014. CO: 4.75 (-0.06)
China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2015 Financial Results
PR Newswire - Tue Nov 18, 6:00AM CST
China Cord Blood Corporation (NYSE: CO) (the "Company"
today announced its plan to release financial results for the second quarter and first half of fiscal year 2015 on Tuesday, November 25, 2014, after market close in the US. CO: 4.75 (-0.06)
Complete 2015-16 Global Cord Blood Banking Industry Report
M2 - Fri Nov 14, 6:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/cr26gf/complete_201516) has announced the addition of the "Complete 2015-16 Global Cord Blood Banking Industry Report" report to their offering. The report is designed to guide the decision-making of cord blood banks worldwide, as well as to advise private, corporate, and institutional investors entering into this market. As such, it considers a range of metrics that impact the global cord blood banking market. It includes trend rate data for cord blood clinical trials, patents, grants, scientific publications and more. For instance, there are now more than 500 studies involving cord blood listed on www.ClinicalTrials.gov, and there have been hundreds of patents related to cord blood collection, processing, and storage filed through the United States Patent and Trademark Office (www.USPTO.gov). Globally, this patent count is even larger. Additionally, the year-over-year increase in scientific publications on PubMed.gov containing the term cord blood increased by 7.8% from 2013 to 2014. PubMed.gov is a global database of scientific publications containing more than 24 million citations for biomedical literature, which makes it an excellent resource for gauging biomedical research trends. However, grant rate data reveals that funding for cord blood related research has been declining from 2012 to present. This comprehensive overview consists of 4 documents: - Complete 2015-16 Global Cord Blood Industry Report - Cord Blood Survey: 600 Recent and Expectant Parents - Cord Blood Industry Database - Part 1 - Cord Blood Industry Database - Part 2 Key report findings include: - Market size determinations for the global cord blood market - Trend rate data for umbilical cord blood grants, patents, and scientific publications - Clinical trial rate analysis, including comparison of cord blood vs. cord tissue frequency - Rates of global cord blood storage (units per year) - Rates of global cord blood transplant (units per year) - Current and future conditions treatable with cord blood - Probability of requiring a stem cell transplant by age - Trends in medical opinions of cord blood banking - Changes in legislative support for cord blood banking - Critical events and emerging technologies within the cord blood industry - Competitive environment analysis, including assessment of cord blood market leaders - Influential alliances within the cord blood industry - "SWOT" analysis for global cord blood industry (Strengths, Weaknesses, Opportunities, Threats) - Crucial trends and unmet market needs Companies Mentioned - China Cord Blood Corporation - HealthBanks Biotech Company Ltd. - Cord Blood Registry For more information visit http://www.researchandmarkets.com/research/cr...ete_201516
CO: 4.75 (-0.06)
InsiderInsights.com Daily Round Up 11/10/14: CHK, TWX, SGEN, PBFX
InsiderInsights - at Seeking Alpha - Tue Nov 11, 2:29AM CST
HAS: 62.74 (+0.58), VR: 42.10 (+0.07), SEIC: 43.20 (+0.07), DRNA: 21.30 (-0.06), HA: 18.72 (-0.31), SAM: 303.26 (-0.97), PBFX: 23.40 (+0.95), AMRI: 16.94 (-0.28), GSAT: 2.40 (+0.08), TNET: 36.49 (+0.76), TWX: 83.87 (+0.56), HLT: 28.57 (+0.13), Q: 63.31 (+0.06), SGEN: 31.57 (+0.36), CF: 301.40 (-1.20), OPK: 13.80 (-0.28), CHK: 21.08 (+0.58), CNDO: 2.28 (+0.03), CO: 4.75 (-0.06), CPLA: 65.23 (-1.37)
China Cord Blood Corp: A Great Company With Substantial Potential Upside
The Kumquat - at Seeking Alpha - Tue Oct 28, 7:52AM CDT
CO: 4.75 (-0.06)
China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 11, 2014
PR Newswire - Fri Sep 26, 6:00AM CDT
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"
, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 2014 annual general meeting of shareholders at its Hong Kong office at 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong, at 9:00 p.m. Hong Kong Time on December 11, 2014 (8:00 a.m. U.S. Eastern Time on December 11, 2014). CO: 4.75 (-0.06)
CO, TSYS Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Wed Sep 24, 3:40AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of China Cord Blood Corp (NYSE:CO), TeleCommunication Systems Inc (NASDAQ:TSYS) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
TSYS: 3.28 (-0.03), CO: 4.75 (-0.06)
